Literature DB >> 22920261

Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model.

Heekyung Lee1, Dino Dvorak, Hsin-Yi Kao, Áine M Duffy, Helen E Scharfman, André A Fenton.   

Abstract

Brain abnormalities acquired early in life may cause schizophrenia, characterized by adulthood onset of psychosis, affective flattening, and cognitive impairments. Cognitive symptoms, like impaired cognitive control, are now recognized to be important treatment targets but cognition-promoting treatments are ineffective. We hypothesized that cognitive training during the adolescent period of neuroplastic development can tune compromised neural circuits to develop in the service of adult cognition and attenuate schizophrenia-related cognitive impairments that manifest in adulthood. We report, using neonatal ventral hippocampus lesion rats (NVHL), an established neurodevelopmental model of schizophrenia, that adolescent cognitive training prevented the adult cognitive control impairment in NVHL rats. The early intervention also normalized brain function, enhancing cognition-associated synchrony of neural oscillations between the hippocampi, a measure of brain function that indexed cognitive ability. Adolescence appears to be a critical window during which prophylactic cognitive therapy may benefit people at risk of schizophrenia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920261      PMCID: PMC3437240          DOI: 10.1016/j.neuron.2012.06.016

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  86 in total

1.  Remediation of memory disorders in schizophrenia.

Authors:  A Medalia; N Revheim; M Casey
Journal:  Psychol Med       Date:  2000-11       Impact factor: 7.723

Review 2.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 3.  Neural syntax: cell assemblies, synapsembles, and readers.

Authors:  György Buzsáki
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

4.  Theta-gamma coupling increases during the learning of item-context associations.

Authors:  Adriano B L Tort; Robert W Komorowski; Joseph R Manns; Nancy J Kopell; Howard Eichenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

5.  Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia.

Authors:  Karuna Subramaniam; Tracy L Luks; Melissa Fisher; Gregory V Simpson; Srikantan Nagarajan; Sophia Vinogradov
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

6.  Neurocognitive functioning in a group of offspring genetically at high-risk for schizophrenia in Eastern Turkey.

Authors:  Erol Ozan; Erdem Deveci; Meltem Oral; Utku Karahan; Elif Oral; Nazan Aydin; Ismet Kirpinar
Journal:  Brain Res Bull       Date:  2010-05-07       Impact factor: 4.077

7.  Schizophrenia as a disorder of cerebral state transition.

Authors:  J J Wright; R R Kydd
Journal:  Aust N Z J Psychiatry       Date:  1986-06       Impact factor: 5.744

Review 8.  Schizophrenia and the mechanisms of conscious integration.

Authors:  G Tononi; G M Edelman
Journal:  Brain Res Brain Res Rev       Date:  2000-03

Review 9.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

10.  Gamma rhythms and beta rhythms have different synchronization properties.

Authors:  N Kopell; G B Ermentrout; M A Whittington; R D Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

View more
  49 in total

Review 1.  Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Authors:  Meng-Lin Li; Xi-Quan Hu; Feng Li; Wen-Jun Gao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

Review 2.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

3.  Developmental timing and critical windows for the treatment of psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

Review 4.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

Review 5.  Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

Authors:  Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

Review 6.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

7.  Tracking recurrence of correlation structure in neuronal recordings.

Authors:  Samuel A Neymotin; Zoe N Talbot; Jeeyune Q Jung; André A Fenton; William W Lytton
Journal:  J Neurosci Methods       Date:  2016-10-13       Impact factor: 2.390

8.  Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.

Authors:  Sungro Jo; Tatiana L Fonseca; Barbara M L C Bocco; Gustavo W Fernandes; Elizabeth A McAninch; Anaysa P Bolin; Rodrigo R Da Conceição; Joao Pedro Werneck-de-Castro; Daniele L Ignacio; Péter Egri; Dorottya Németh; Csaba Fekete; Maria Martha Bernardi; Victoria D Leitch; Naila S Mannan; Katharine F Curry; Natalie C Butterfield; J H Duncan Bassett; Graham R Williams; Balázs Gereben; Miriam O Ribeiro; Antonio C Bianco
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

Review 9.  Cellular and circuit models of increased resting-state network gamma activity in schizophrenia.

Authors:  R S White; S J Siegel
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

10.  Phencyclidine Discoordinates Hippocampal Network Activity But Not Place Fields.

Authors:  Hsin-Yi Kao; Dino Dvořák; EunHye Park; Jana Kenney; Eduard Kelemen; André A Fenton
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.